(PharmaNewsWire.Com, February 12, 2019 ) Netscribes' latest market research report titled Oncology Pharmaceutical Market in India 2014 highlights the analysis of the drivers and explains the factors for growth of the industry. Increasing number of cancer cases are the key drivers of this market. Lung, stomach, colon and breast cancer cause the maximum number of cancer deaths each year. Pharmaceutical companies are progressively increasing R&D expenditure on cancer vaccines. The growing number of patients seeking treatment for cancer has made hospitals realize that cancer treatment is an important area for growth. Gleevec, Mabthera, Iressa, Avastin, Grafeel, Soliris and Herceptin are the top selling cancer drugs in the Indian market.
Alternative therapies such as cancer gene therapy and cancer cell therapy are increasingly becoming popular in cases where conventional therapies have failed. Combination therapies are being increasingly used in cancer treatments. Some challenges faced by the industry are the internal competition between large pharmaceutical companies. Another challenge is the penetration of Oncological drugs in rural areas which is very low. Various government initiatives have been undertaken to reduce the drug prices and various tax reforms and control programs are promoting the growth of the market as well. Manufacture of generic oncology drugs will help the pharmaceutical manufacturer gain a competitive advantage over others in a highly competitive pharma market. Companies should focus on development of new molecules in order to prolong the longevity of a blockbuster drug in the market.
Introduction Slide 5-6: Types of Chemotherapy drugs
Market Overview Slide 7-9: Global Oncology Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e), Indian Oncology Pharmaceutical Market - Overview, Market Size & Growth (2013-2018e), Regions with high cancer prevalence, Top 5 cancer's in India
Export-Import Slide 10-11: Region wise Exports, Total Exports, Region wise Imports, Total Imports
Value Chain Slide 12-13: Market Value Chain Analysis
Government Initiatives Slide 23: Government Initiatives - Summary Slide 24: Helping the Market to grow Slide 25: National List of Essential Medicines (NLEM), Jan Aushadhi Stores (JAS) Slide 26-27: cancer awareness programmes Slide 28: Reduction in Excise Duties
Regulations Slide 29: Licensing and registration of pharmaceuticals Slide 30: Various other regulatory frameworks Slide 31-33: Patent Approvals
Competitive Landscape Slide 34: Porter's Five Forces Analysis Slide 35: Public Trading Comparables, Top 3 Companies Slide 36-38: Competitive Benchmarking, Key Ratios of Top 3 Companies - Operational Basis (FY 2013) Slide 39: Competitive Benchmarking, Key Ratios of Top 3 Companies - Financial Basis (FY 2013) Slide 40-75: Major Public Players Slide 76-85: major Private Players
Research Report Hub Research Report Hub offers wide-ranging collection of market research reports under virtually every market verticals and sub-categories from different publishers across the globe. We offer reliable market intelligence reports and report customization services to better understand current and projected market scenarios. It also gives a clearer depiction of industries and facilitates to simply perceive competitor activity in the respective industry. Our services are also geared towards helping organizations procure market reports at the finest price.
About US
Research Report Hub Sector 04, Plot 101, Sant Nagar, Moshi PCNDTA, Pune, 412105 Maharashtra, India
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: